Solara Active Pharma Sciences Announces Q3 and Nine Months Results for 2025, Expects to Raise Rs. 134.99 Crores

Solara Active Pharma Sciences Ltd. has reported its unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended December 31, 2025. The company reported a loss of Rs. 17.01 crores for the nine-month period. To mitigate the situation and fund its operations, Solara Active Pharma Sciences expects to raise Rs. 134.99 crores through the pending final call of its rights issue. The company's operations relate to the Active Pharmaceutical Ingredient (API) segment.